Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
GlobeNewswire, Inc.
Company announcement No. 45 / 2026 Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, September 2, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no....
Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer
GlobeNewswire, Inc.
Dr. Røpcke joins Resalis with extensive experience in clinical drug development as well as expertise in obesity and cardiometabolic therapy areas Torino, Italy, September 2, 2026 – Resalis Therapeutics, a biotechnology company pioneering...
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
GlobeNewswire, Inc.
Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a...
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
GlobeNewswire, Inc.
Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Silverado Returns to Salt Lake City with Reacquisition of Aspen Park Memory Care Community
EIN Presswire
Silverado brings nearly 30 years of dementia care expertise, internationally recognized training and innovative 24-hour brain health back to Salt Lake Valley.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 43 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 28, 2026 – Zealand Pharma...
AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041
GlobeNewswire, Inc.
Patent protections establish long-duration intellectual property coverage for Ampligen across major European markets and the United Kingdom Latest milestone further strengthens AIM’s expanding global Ampligen patent estate across multiple...
Nordicus Partners Corporation Appoints Elizabeth Addonizio to Its Board of Directors
GlobeNewswire, Inc.
Appointment strengthens board independence and financial expertise as Company advances its clinical pipeline.
Zealand Pharma – Notification of holding of treasury shares
GlobeNewswire, Inc.
Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
Food as Medicine Market to Reach USD 400.81 Billion by 2031, Growing at a CAGR of 9.5% — MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL , Aug. 24, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ estimates the global food as medicine Industry to grow from USD 254.15 billion in 2026 to USD 400.81 billion by 2031, registering a CAGR of 9.5% during the forecast period....
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
GlobeNewswire, Inc.
Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Smartpatient and Novo Nordisk Expand Patient Support Partnership Across Additional Treatment Formats
EIN Presswire
The expansion builds on a digital obesity care program launched in 2025 and extended to Type 2 diabetes earlier in 2026. MUNICH, GERMANY, September 2, 2026 /EINPresswire.com/ -- Smartpatient and Novo Nordisk are expanding their patient support...
A New Framework Establishes 'The Hallmarks of Skeletal Muscle Health'
EIN Presswire
An international consortium of experts outlines a unifying conceptual framework to transform precision diagnostics, therapeutics, and healthy aging strategies TORONTO, CANADA, August 20, 2026 /EINPresswire.com/ -- Today, an international team of...
UNCF Announces Historic $12 Million Gift from The James and Judith K. Dimon Foundation to Strengthen HBCU Endowments and Expand Pathways in Healthcare and Education
GlobeNewswire, Inc.
Washington, DC, Aug. 20, 2026 (GLOBE NEWSWIRE) -- UNCF announced The Dimon Fund to Advance Economic Opportunity, a historic $12 million gift from The James and Judith K. Dimon Foundation to strengthen the long-term sustainability of historically...
Precision Control, Verified Quality: KEPUNI's 26 Patents, Global Service & High-End Partnerships Build Brand Moat
EIN Presswire
First-pass yield consistently exceeding 99% (industry average 75%), weld precision of ±0.05mm, compliant with FDA, GMP, ASME and other international standards.
Alveus Therapeutics Strengthens Executive Leadership Team, Opens Boston office
GlobeNewswire, Inc.
BOSTON and COPENHAGEN, Denmark, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Alveus Therapeutics Inc. (“Alveus”), a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, today announced two key...
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
GlobeNewswire, Inc.
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Zealand Pharma Announces Financial Results for the First Half of 2026
GlobeNewswire, Inc.
Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of...
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
GlobeNewswire, Inc.
Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its...
Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
GlobeNewswire, Inc.
COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases https://doi.org/10.1093/cid/ciag446 describing the use of SNIPR001 in a...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.